Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: A systematic review

International Journal of Dermatology

Volumn 53, Issue 11, 2014, Pages 1305-1318

  Zhang, Claire Shuiqing ^a   Yu, Jason Jingjie ^a,b   Parker, Shefton ^a   Zhang, Anthony Lin ^a   May, Brian ^a   Lu, Chuanjian ^a,b   Xue, Charlie Changli ^a,b  

^a RMIT UNIVERSITY   (Australia)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CHOLESTEROL; CLOBETASOL PROPIONATE; ETRETIN; HERBACEOUS AGENT; KERATOLYTIC AGENT;

ANGELICA SINENSIS; ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; CHINA; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG THERAPY; DRY SKIN; FOLLOW UP; GASTROINTESTINAL DISEASE; HERBAL MEDICINE; HUMAN; LEUKOCYTE DISORDER; LITHOSPERMUM; LITHOSPERMUM ERYTHRORHIZON; META ANALYSIS; OUTCOME ASSESSMENT; PAEONIA; PAEONIA VEITCHII; PLANT ROOT; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHMANNIA GLUTINOSA; REVIEW; RISK ASSESSMENT; SALVIA MILTIORRHIZA; SARSAPARILLA; SIDE EFFECT; SKIN DISEASE; SKIN IRRITATION; SKIN PRURITUS; SKIN SCALE; SMILAX GLABRA; STOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT DURATION; XEROSTOMIA; ADVERSE EFFECTS; DRUG COMBINATION; PHYTOTHERAPY; PSORIASIS; REHMANNIA;

ACITRETIN; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; HUMANS; KERATOLYTIC AGENTS; LITHOSPERMUM; PHYTOTHERAPY; PLANT ROOTS; PSORIASIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REHMANNIA; SALVIA MILTIORRHIZA;

EID: 84911967356     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12607     Document Type: Review

References (50)

1. Raut AS, Prabhu RH, Patravale VB. Psoriasis clinical implications and treatment: a review. Crit Rev Ther Drug Carrier Syst 2013; 30: 183-216.
2. Cimmino MA. Epidemiology of psoriasis and psoriatic arthritis. Reumatismo 2007; 59(Suppl. 1): 19-24.
3. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008; 58: 826-850.
4. Basavaraj KH, Navya MA, Rashmi R. Stress and quality of life in psoriasis: an update. Int J Dermatol 2011; 50: 783-792.
5. Sampogna F, Tabolli S, Abeni D. Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life. Acta Derm Venereol 2012; 92: 299-303.
6. Levy AR, Davie AM, Brazier NC, et al. Economic burden of moderate to severe plaque psoriasis in Canada. Int J Dermatol 2012; 51: 1432-1440.
7. Nast A, Boehncke WH, Mrowietz U, et al. S3 - Guidelines on the treatment of psoriasis vulgaris (English version) Update. J Dtsch Dermatol Ges 2012; 10(Suppl. 2): S1-S95.
8. Tang MM, Chang CC, Chan LC, et al. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study. Int J Dermatol 2013; 52: 314-322.
9. May BH, Zhang AL, Zhou W, et al. Oral herbal medicines for psoriasis: a review of clinical studies. Chin J Integr Med 2012; 18: 172-178.
10. Wang G, Liu Y. Traditional Chinese medicine is effective and safe in the treatment of psoriasis. Int J Dermatol 2004; 43: 552.
11. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.2011.
12. Huang JM. Clinical observation of integration of traditional and Western medicine for psoriasis. J Tradit Chin Med 2010: 29 22. (in Chinese).
13. Wan HL. Clinical observation of integration of Chinese medicine and Western medicine treatment for psoriasis. Guide China Med 2012; 10: 210-211 (in Chinese).
14. Xie Y. Clinical effect of Tuiyin decoction combined with acitretin capsules for psoriasis vulgaris. J Pract Tradit Chin Med 2006; 22: 684-685 (in Chinese).
15. Luo XF. The observe of clinical therapeutic effect on the treatment of psoriasis with acitretin capsules combined with Chinese herbal compound. Master thesis, Hubei University of Chinese Medicine, 2010 (in Chinese).
16. Mao H, Mao YH. Clinical observation of integration of Chinese medicine and western medicine treatment for psoriasis vulgaris. China Healthc Innov 2007; 19: 64. (in Chinese).
17. Chen BY, Tan XL. Diyin tablets combined with Kang Yinxie Fang for the treatment of psoriasis vulgaris. Guangdong Med J 2004; 25: 727-728 (in Chinese).
18. Jin L, Ma YB, Jiang YS, et al. Topical calcipotriol ointment therapy combination with oral Chinese medicine treatment in plaque psoriasis vulgaris. Chin J Dermatovenereol Integr Tradit West Med 2009; 4: 216-218. (in Chinese).
19. Tian Y. Qingfei Liangxue decoction clinical study of psoriasis vulgaris. J Liaoning Univ Tradit Chin Med 2011; 6: 187-189. (in Chinese).
20. Wu SM, Wu Y, Bai Y, et al. Clinical observation of Acitretin combined with Yinxiekang for psoriasis vulgaris. Chin J Dermatovenereol Integr Tradit West Med 2009; 4: 228-229. (in Chinese).
21. Zheng XT. Xiaoyin Kebi Decoction for 60 psoriasis vulgaris patients. Henan Tradit Chin Med 2011; 4: 383-384. (in Chinese).
22. Liu ZX. Clinical observation in the use of decoction of Jian Pi Yi Shen Tang on the treatment of patients with regressive psoriasis vulgaris. Xinjiang J Tradit Chin Med 2005; 5: 46-47. (in Chinese).
23. Zhang ZH. Clinical observation of integration of traditional and western medicine for 56 patients with psoriasis vulgaris. Guide China Med 2012; 16: 275-276. (in Chinese).
24. Chen H. Jiedu Huazhuo combined with acitretin capsule for 150 patients with progressive psoriasis vulgaris. Jiangsu J Tradit Chin Med 2010; 8: 21-22. (in Chinese).
25. Kong HY. Clinical observation of integration of traditionla and western medicine for psoriasis. Nei Menggu J Tradit Chin Med 2007; 3: 22-23. (in Chinese).
26. Shen WG, Zhao SJ. Clinical observation of Xiaoyin decoction combined with Diyin tablets for 30 patients with psoriasis. Nei Menggu J Tradit Chin Med 2005; 5: 12. (in Chinese).
27. Tan DM, Li DL. Clinical observation of integration of traditionla and western medicine for psoriasis. Nei Menggu J Trad Chin Med 2010; 3: 55-56. (in Chinese).
28. Yu LL, Pan XL. Clinical effects and quality of life of 96 patients with psoriasis vulgaris treated with integrative Chinese and western medicine. Shanghai J Trad Chin Med 2007; 1: 43-44. (in Chinese).
29. Song SH, Wang YJ, Zhang JZ, et al. Combination of Chinese herbal medicine, Diyin tablets and Chinese herbal medicine bath for the treatment of psoriasis. Chin J Dermatol Venereol 2013; 4: 402-404. (in Chinese).
30. Yang QY. Diyin tablet for the treatment of psoriasis. Jilin Med J 2011; 18: 3686-3687.
31. Zhu SP, Hu SS. Clinical ustilisation of "Compound glycyrrhizin solution". Anhui Med J 2011; 2: 235-238. (in Chinese).
32. Zhao B. Clinical Dermatology. Jiangsu, China: Jiangsu Science and Technology Publishing House, 2009 (in Chinese).
33. China Academy of Chinese Medicine. Evidence-based Guidelines of Clinical Practice in Chinese Medicine Specific Disease. Beijing: China Press of Traditional Chinese Medicine, 2011 (in Chinese)
34. Chinese Medical Association. Consensus on integrative medicine diagnosis and treatment of psoriasis vulgaris. Chin J Dermatovenereol Integr Tradit West Med 2009; 42: 213-214. (in Chinese).
35. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 28: 1987-1991.
36. Liu CL, Cheng L, Ko CH, et al. Bioassay-guided isolation of anti-inflammatory components from the root of Rehmannia glutinosa and its underlying mechanism via inhibition of iNOS pathway. J Ethnopharmacol 2012; 143: 867-875.
37. Baek GH, Jang YS, Jeong SI, et al. Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products. Inflammation 2012; 35: 1232-1241.
38. Choi HJ, Jang HJ, Chung TW, et al. Catalpol suppresses advanced glycation end-products-induced inflammatory responses through inhibition of reactive oxygen species in human monocytic THP-1 cells. Fitoterapia 2013; 86: 19-28.
39. Zhang X, Jin C, Li Y, et al. Catalpol improves cholinergic function and reduces inflammatory cytokines in the senescent mice induced by D-galactose. Food Chem Toxicol 2013; 58: 50-55.
40. Kim H, Lee E, Lee S, et al. Effect of Rehmannia glutinosa on immediate type allergic reaction. Int J Immunopharmacol 1998; 20: 231-240.
41. Kim HM, An CS, Jung KY, et al. Rehmannia glutinosa inhibits tumour necrosis factor-alpha and interleukin-1 secretion from mouse astrocytes. Pharmacol Res 1999; 40: 171-176.
42. Wang X, Morris-Natschke SL, Lee KH. New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med Res Rev 2007; 27: 133-148.
43. Li FL, Xu R, Zeng QC, et al. Tanshinone IIA inhibits growth of keratinocytes through cell cycle arrest and apoptosis: underlying treatment mechanism of psoriasis. Evid Based Complement Alternat Med 2012; 2012: 927658.
44. Pedersen E, Wang Z, Stanley A, et al. RAC1 in keratinocytes regulates crosstalk to immune cells by Arp2/3-dependent control of STAT1. J Cell Sci 2012; 125(Pt 22): 5379-5390.
45. Hisa T, Kimura Y, Takada K, et al. Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro. Anticancer Res 1998; 18: 783-790.
46. Yingkun N, Lvsong Z, Huimin Y. Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells. Can J Physiol Pharmacol 2010; 88: 1138-1146.
47. Wang H, Wu C, Wan S, et al. Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin beta1 expression and the ERK1/2 signaling pathway. Toxicology 2013; 308: 104-112.
48. Han KY, Kwon TH, Lee TH, et al. Suppressive effects of Lithospermum erythrorhizon extracts on lipopolysaccharide-induced activation of AP-1 and NF-kappaB via mitogen-activated protein kinase pathways in mouse macrophage cells. BMB Rep 2008; 41: 328-333.
49. Kim EK, Kim EY, Moon PD, et al. Lithospermi radix extract inhibits histamine release and production of inflammatory cytokine in mast cells. Biosci Biotechnol Biochem 2007; 71: 2886-2892.
50. Kim J, Kim Y, Seo D, et al. Oral supplementation of Lithospermum erythrorhizon prevents the development of atopic dermatitis with reducing ceramide degradation in the epidermis of NC/Nga mice. Phytother Res 2009; 23: 1250-1256.